Afya Limited (NASDAQ:AFYA – Get Free Report) was the target of a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 1,240,000 shares, an increase of 8.8% from the December 15th total of 1,140,000 shares. Currently, 9.2% of the shares of the company are sold short. Based on an average trading volume of 119,500 shares, the short-interest ratio is presently 10.4 days.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on the stock. The Goldman Sachs Group initiated coverage on shares of Afya in a research note on Tuesday, December 3rd. They set a “sell” rating and a $16.00 price objective on the stock. JPMorgan Chase & Co. lowered their price objective on Afya from $25.00 to $20.50 and set a “neutral” rating on the stock in a report on Friday. One equities research analyst has rated the stock with a sell rating and four have given a hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $19.60.
Read Our Latest Research Report on AFYA
Institutional Investors Weigh In On Afya
Afya Price Performance
Shares of AFYA opened at $15.74 on Tuesday. The stock has a fifty day simple moving average of $15.92 and a two-hundred day simple moving average of $16.74. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 0.51. Afya has a 52-week low of $14.52 and a 52-week high of $22.48.
About Afya
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Featured Stories
- Five stocks we like better than Afya
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- Insider Buying Explained: What Investors Need to Know
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- How to Use the MarketBeat Excel Dividend Calculator
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.